4D Pharma PLC (LON: DDDD), a clinical stage biopharmaceutical company, pioneering the development of Live Biotherapeutic Products, today announced an agreement with a subsidiary of MSD (tradename of Merck &

4D pharma plc (LON:DDDD), a pharmaceutical company leading the development of live biotherapeutics, today announced that the Company has submitted, and the Medicines and Healthcare products Regulatory Agency (MHRA) has cleared,

4D pharma plc (LON:DDDD), a pharmaceutical company leading the development of live biotherapeutics, has today announced that the Company has submitted, and the U.S. Food and Drug Administration (FDA) has cleared,

4D pharma plc (LON:DDDD), a pharmaceutical company focusing on the development of live biotherapeutics, today announced that the Annual Report and Accounts for the year to 31 December 2017 and

4D pharma plc (LON:DDDD), a pharmaceutical company focusing on the development of live biotherapeutics, today provided the following update in relation to the development of its lead oncology candidate, MRx0518. MRx0518

4D pharma PLC (LON:DDDD), a pharmaceutical company focusing on the development of live biotherapeutics, announced that it has with immediate effect appointed Bryan Garnier & Co. Limited as its joint corporate broker,

After losing his wife, Cambridge entrepreneur is determined his breath test device will make a difference. Billy Boyle is a man on a mission, and that mission is to save

4D pharma PLC (LON:DDDD), a pharmaceutical company focussing on the development of live biotherapeutics targeting important new therapeutic areas, has today announced the interim results for the Company and its subsidiaries

4D pharma plc (LON:DDDD), a pharmaceutical company focusing on the development of live biotherapeutics, announced today that it allotted 635,692 new ordinary shares on 23 August 2017. The allotment represents